MétaCan
Menu
Back to cohort
Record W4311408628 · doi:10.21203/rs.3.rs-2238095/v1

Subcutaneous immunoglobulin replacement therapy in patients with immunodeficiencies – impact of drug packaging and administration method on patient-reported outcomes

2022· preprint· en· W4311408628 on OpenAlexaffabout
Rajiv Mallick, G. Solomon, Paul Bassett, X. Zhang, P. Patel, Oleksandra Lepeshkina

Bibliographic record

VenueResearch Square · 2022
Typepreprint
Languageen
FieldImmunology and Microbiology
TopicImmunodeficiency and Autoimmune Disorders
Canadian institutionsCentre hospitalier de l'Université Laval
FundersCSL Behring
KeywordsVialMedicineInfusion pumpPatient satisfactionSurgeryAnesthesia

Abstract

fetched live from OpenAlex

Abstract Background:Understanding the impact of subcutaneous immunoglobulin (SCIg) packaging (vials and pre-filled syringes [PFS]) and administration methods (pump and manual push) upon treatment experience can potentially facilitate optimization of patient outcomes. Here, the perspective of patients with primary and secondary immunodeficiency receiving SCIg was evaluated. Methods: An online survey conducted by the Associatin des Patients Immunodéficients du Québec (APIQ) (10/2020–03/2021) of patients in Canada contained questions on SCIg use: reasons for choosing packaging and administration methods, training experiences, self‑infusion characteristics, and switching packaging methods. The survey captured structured patient‑reported outcomes such as treatment satisfaction (via TSQM), symptom state (via PASS), general health perception (via GHP), and physical and mental function (via PROMIS). Respondents using SCIg were compared by their SCIg packaging, and then stratified by their administration method in a sub-analysis. Results: Sixty-six respondents were currently using vials, with 38 using a pump and 28 using manual push; 120 respondents were currently using PFS (5 and 10 mL sizes), with 38 using a pump and 82 using manual push. PFS users were associated with a significantly lower SCIg dose (p=0.02), a significantly shorter infusion preparation time (p=0.02), and a trend for shorter actual infusion time (p=0.07) compared with vial users. Treatment satisfaction was similar between vial and PFS users in terms of effectiveness and convenience, both overall and in the manual push subgroup; in the pump subgroup, vial users showed a trend for improved convenience compared with PFS users (p=0.07). Vial users were associated with greater global satisfaction compared with PFS users, both overall and in the manual push subgroup (both p=0.02). Conclusions: PFS users were associated with 17% lower SCIg dose compared with vial users, consistent with wastage caused by drawing the product into syringes from vials. PFS users were also associated with shorter pre-infusion times, reflecting simpler administration mechanics compared with vial users. Higher global satisfaction among vial users compared with PFS users may be due to incompatibility of currently available PFS and pump sizes, and sub-optimal SCIg training delivered during the COVID-19 pandemic; patient experience on PFS is expected to improve once these temporary factors resolve.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.005
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.024
GPT teacher head0.358
Teacher spread0.334 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueResearch SquareSame topicImmunodeficiency and Autoimmune DisordersFrench-language works237,207